Condition: HIV-1 · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of the potent, broadly neutralizing anti-HIV monoclonal antibodies (mAb) PGT121.414.LS alone and in combination with VRC07-523LS soon after birth in infants exposed to HIV-1.
This description comes directly from the study's public registry record.
Emily Brown · 919-321-3806 · embrown@fhi360.org
Always discuss trial participation with your own doctor first.
| Site 5112, David Geffen School of Medicine at UCLA | Los Angeles, California, United States | Not Yet Recruiting |
| Site 5052, University of Colorado Denver | Aurora, Colorado, United States | Recruiting |
| Site 5051, University of Florida Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Site 5127, Pediatric Perinatal HIV | Miami, Florida, United States | Withdrawn |
| Site 5030, Emory University School of Medicine | Atlanta, Georgia, United States | Not Yet Recruiting |
| Site 5083, Rush University Cook County Hospital Chicago | Chicago, Illinois, United States | Not Yet Recruiting |
| Site 5092, Johns Hopkins University Baltimore | Baltimore, Maryland, United States | Recruiting |
| Site 5114, Bronx-Lebanon Hospital Center | The Bronx, New York, United States | Recruiting |
| Site 5013, Jacobi Medical Center Bronx | The Bronx, New York, United States | Not Yet Recruiting |
| Site 6501, St. Jude Children's Research Hospital | Memphis, Tennessee, United States | Not Yet Recruiting |
| Site 5128, Baylor College of Medicine/Texas Children's Hospital | Houston, Texas, United States | Recruiting |
| Site 5072, Hospital Federal dos Servidores do Estado | Rio de Janeiro, Brazil | Not Yet Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06517693